Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans von Moon, Sohee, Kim, Sujin, Mankhong, Sakulrat, Choi, Seong Hye, Vandijck, Manu, Kostanjevecki, Vesna, Jeong, Jee Hyang, Yoon, Soo Jin, Park, Kyung Won, Kim, Eun-Joo, Yoon, Bora, Kim, Hee Jin, Jang, Jae-Won, Hong, Jin Yong, Park, Dong-Ho, Shaw, Leslie M, Kang, Ju-Hee

Volltext

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology von Sandelius, Åsa, Portelius, Erik, Källén, Åsa, Zetterberg, Henrik, Rot, Uros, Olsson, Bob, Toledo, Jon B., Shaw, Leslie M., Lee, Virginia M.Y., Irwin, David J., Grossman, Murray, Weintraub, Daniel, Chen-Plotkin, Alice, Wolk, David A., McCluskey, Leo, Elman, Lauren, Kostanjevecki, Vesna, Vandijck, Manu, McBride, Jennifer, Trojanowski, John Q., Blennow, Kaj

Volltext

AD biomarker stability for stored CSF based on immunoassay results: Biomarkers (non‐neuroimaging) / Method development and/or quality control von Vandijck, Manu, Bastard, Nathalie Le, Persson, Staffan, Zetterberg, Henrik, Blennow, Kaj, Kostanjevecki, Vesna

Volltext

AD biomarker stability for stored CSF based on immunoassay results von Vandijck, Manu, Bastard, Nathalie Le, Persson, Staffan, Zetterberg, Henrik, Blennow, Kaj, Kostanjevecki, Vesna

Volltext

First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays von Boulo, Sébastien, Kuhlmann, Julia, Andreasson, Ulf, Brix, Britta, Venkataraman, Iswariya, Herbst, Victor, Rutz, Sandra, Manuilova, Ekaterina, Vandijck, Manu, Dekeyser, Filip, Bjerke, Maria, Pannee, Josef, Charoud‐Got, Jean, Auclair, Guy, Mazoua, Stéphane, Pinski, Gregor, Trapmann, Stefanie, Schimmel, Heinz, Emons, Hendrik, Quaglia, Milena, Portelius, Erik, Korecka, Magdalena, Shaw, Leslie M., Lame, Mary, Chambers, Erin, Vanderstichele, Hugo, Stoops, Erik, Leinenbach, Andreas, Bittner, Tobias, Jenkins, Rand G., Kostanjevecki, Vesna, Lewczuk, Piotr, Gobom, Johan, Zetterberg, Henrik, Zegers, Ingrid, Blennow, Kaj

Volltext

ANALYTICAL PERFORMANCE OF A FULLY AUTOMATED CHEMILUMINESCENT β-AMYLOID 1-40 ASSAY ON THE LUMIPULSE G SERIES von Dobbels, Caroline, Denoyette, Mario, Riems, Nora, D'hont, Jelle, Vandijck, Manu, Degrieck, Rosina, Kostanjevecki, Vesna, Jannes, Geert

Volltext

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements von Bjerke, Maria, Andreasson, Ulf, Kuhlmann, Julia, Portelius, Erik, Pannee, Josef, Lewczuk, Piotr, Umek, Robert M., Vanmechelen, Eugeen, Vanderstichele, Hugo, Stoops, Erik, Lewis, Jennifer, Vandijck, Manu, Kostanjevecki, Vesna, Jeromin, Andreas, Salamone, Salvatore J., Schmidt, Oliver, Matzen, Anja, Madin, Kairat, Eichenlaub, Udo, Bittner, Tobias, Shaw, Leslie M., Zegers, Ingrid, Zetterberg, Henrik, Blennow, Kaj

Volltext

LUMIPULSE G® CSF AD BIOMARKER CONCORDANCE TO PET IN THE KBASE COHORT von Vandijck, Manu, Moonen, Roger, Lawson, John, Le Bastard, Nathalie, Choi, Seong Hye, Kostanjevecki, Vesna, Kang, Ju-Hee

Volltext

P4‐552: LUMIPULSE G® CSF AD BIOMARKER CONCORDANCE TO PET IN THE KBASE COHORT von Vandijck, Manu, Moonen, Roger, Lawson, John, Le Bastard, Nathalie, Choi, Seong Hye, Kostanjevecki, Vesna, Kang, Ju-Hee

Volltext

P4‐075: LUMIPULSE® G TOTAL TAU TO β‐AMYLOID 1‐42 RATIO CUT‐POINT DETERMINATION FOR AMYLOID ELIGIBILITY SCREENING von Kaplow, June, Vandijck, Manu, Moonen, Roger, De Decker, Bart, Zhao, Jim, Lawson, John, Huyck, Els, Le Bastard, Nathalie, Kostanjevecki, Vesna, Luthman, Johan

Volltext

ANALYTICAL PERFORMANCE OF A FULLY AUTOMATED CHEMILUMINESCENT PTAU 181 ASSAY ON THE LUMIPULSE G SERIES von Dauwe, Martine, Dekeyser, Filip, Van Hecke, Pieter, De Geyter, Koen, Vandeponseele, Paul, Dekeersmaeker, Nathalie, Moonen, Roger, Vandijck, Manu, Kostanjevecki, Vesna, Jannes, Geert

Volltext

Correlation of the modified innotest β-amyloid 1-42 with a lc-ms/ms candidate reference method von Vandijck, Manu, Moonen, Roger, Andreasson, Ulf, Le Bastard, Nathalie, Dauwe, Martine, Blennow, Kaj, Kostanjevecki, Vesna

Volltext

LUMIPULSE® G TOTAL TAU: KEY PERFORMANCES OF A FULLY AUTOMATED CHEMILUMINESCENT IMMUNOASSAY von Vandijck, Manu, Dauwe, Martine, Huyck, Els, Le Bastard, Nathalie, Lawson, John, Traynham, Christopher, Vucetic, Zivjena, Gobom, Johan, Blennow, Kaj, Jannes, Geert, Kostanjevecki, Vesna

Volltext

Correlation of the modified innotest β-amyloid1-42 with a lc-ms/ms candidate reference method von Vandijck, Manu, Moonen, Roger, Andreasson, Ulf, Le Bastard, Nathalie, Dauwe, Martine, Blennow, Kaj, Kostanjevecki, Vesna

Volltext

Use of artificial cerebrospinal fluid (aCSF) in immunoassays: Findings and pitfalls von Vandijck, Manu, Decraemer, Hilde, Vanoverbeke, Muriel, Kostanjevecki, Vesna

Volltext

USE OF CSF AB1-42 AND AB1-40 IN THE CLINICAL TYPING OF ALZHEIMER’S DISEASE von Vandijck, Manu, Moonen, Roger, Le Bastard, Nathalie, Dauwe, Martine, Vernoux, Laura, Chevalier, Sylvie, Barthelaix, Annick, Coart, Els, Huyck, Els, Jannes, Geert, Kostanjevecki, Vesna

Volltext

P1‐183: Use of CSF AB 1‐42 and AB 1‐40 in the Clinical Typing of Alzheimer’s Disease von Vandijck, Manu, Moonen, Roger, Le Bastard, Nathalie, Dauwe, Martine, Vernoux, Laura, Chevalier, Sylvie, Barthelaix, Annick, Coart, Els, Huyck, Els, Jannes, Geert, Kostanjevecki, Vesna

Volltext

P1‐203: Verification of the Analytical Performance of the Fully Automated Lumipulse g β‐Amyloid 1‐42 and Lumipulse g Total TAU Assays von Vandersteen, Annelies, Pereson, Sandra, Gorteman, Kathleen, Vandezande, Wim, Dekeyser, Filip, Dumont, Tinne, Moonen, Roger, Huyck, Els, Vandijck, Manu, Dauwe, Martine, Kostanjevecki, Vesna, Jannes, Geert

Volltext

P1‐159: IMPROVEMENTS TO INNOTEST® B‐AMYLOID 1‐42 von Leen Jef Vandijck, Manu, Decreamer, Hilde, Moonen, Roger, Darby, Heather, Huyck, Els, Kostanjevecki, Vesna

Volltext

IMPROVEMENTS TO INNOTEST® HTAU AG von Leen Jef Vandijck, Manu, Decraemer, Hilde, De Decker, Bart, Darby, Heather, Huyck, Els, Kostanjevecki, Vesna

Volltext